Pneumocystis jirovecii in immunocompromised patients with rheumatic diseases

被引：2
|
作者：
Casasempere, Paloma Vela [1 ,2 ]
Torregrosa, Paloma Ruiz [3 ]
Sevila, Raquel Garcia [3 ]
机构：
[1] Hosp Gen Univ Alicante, ISABIAL, Secc Reumatol, Alicante, Spain
[2] Univ Miguel Hernandez, Alicante, Spain
[3] Hosp Gen Univ Alicante, Serv Neumol, Alicante, Spain
来源：
REUMATOLOGIA CLINICA | 2020年 / 17卷 / 05期
关键词：
Pneumocystis jirovecii; Immunosuppression; Rheumatic disease; Autoimmune disease; Prophylaxis; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; DOSE GLUCOCORTICOID THERAPY; CONNECTIVE-TISSUE DISEASES; CARINII-PNEUMONIA; OPPORTUNISTIC INFECTIONS; EULAR RECOMMENDATIONS; CONSENSUS GUIDELINES; RISK-FACTORS; MANAGEMENT;
D O I：
10.1016/j.reuma.2020.02.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Infections, including opportunistic infections, are a major and frequent cause of morbidity and mortality in patients with systemic autoimmune and rheumatic diseases. Pneumocystis jirovecii pneumonia, classically considered to be typical of HIV patients, transplanted patients or patients treated with oncological chemotherapy, is appearing increasingly frequently in these patients. Therefore, rheumatologists should know its mechanism of production, clinical manifestations, treatment and prophylaxis, all of which are addressed in this review. (c) 2020 Elsevier Espana, S.L.U. and Sociedad Espanola de Reumatologia y Colegio Mexicano de Reumatologia. All rights reserved.
引用
收藏
页码：290 / 296
页数：7
相关论文
共 50 条
  • [41] How Many Pneumocystis Jirovecii Pneumonia Cases, in CHUS Hospital from 2008 to 2018, Resulted of Omission of Antibioprophylaxis in Patients With Rheumatic Diseases?
    Page, Charles
    Brum-Fernandes, Artur
    [J]. JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1134 - 1134
  • [42] Effectiveness and safety of lower dose sulfamethoxazole/trimethoprim therapy for Pneumocystis jirovecii pneumonia in patients with systemic rheumatic diseases: A retrospective multicenter study
    Ohmura, Shin-ichiro
    Naniwa, Taio
    Tamechika, Shin-ya
    Miyamoto, Toshiaki
    Shichi, Daisuke
    Kazawa, Nobukata
    Iwagaitsu, Shiho
    Maeda, Shinji
    Wada, Jun-ichi
    Niimi, Akio
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2019, 25 (04) : 253 - 261
  • [43] Pneumocystis jirovecii (Pj) quantitative PCR to differentiate Pj pneumonia from Pj colonization in immunocompromised patients
    Maillet, M.
    Maubon, D.
    Brion, J. P.
    Francois, P.
    Molina, L.
    Stahl, J. P.
    Epaulard, O.
    Bosseray, A.
    Pavese, P.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2014, 33 (03) : 331 - 336
  • [44] Protocol for the systematic review of the Pneumocystis jirovecii-associated pneumonia in non-HIV immunocompromised patients
    Orozco-Ugarriza, Mauricio Ernesto
    Olivo-Martinez, Yenifer
    Rodger-Cervantes, Yuranis E.
    [J]. PLOS ONE, 2024, 19 (05):
  • [45] Metagenomic Next-Generation Sequencing Is Highly Efficient in Diagnosing Pneumocystis Jirovecii Pneumonia in the Immunocompromised Patients
    Wang, Dongsheng
    Fang, Shihua
    Hu, Xiaowen
    Xu, Qixia
    Chu, Xinmin
    Mei, Xiaodong
    Xie, Wang
    [J]. FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [46] Co-infection with Pneumocystis jirovecii and invasive pulmonary aspergillosis in severely immunocompromised patients: a diagnostic challenge
    Boch, T.
    Spiess, B.
    Baumann, S.
    Becher, T.
    Hofmann, W-K
    Buchheidt, D.
    Reinwald, M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 160 - 160
  • [47] Microscopic diagnosis of Pneumocystis jirovecii pneumonia in bronchoalveolar lavage and oropharyngeal wash samples of immunocompromised patients with pneumonia
    Rodino, Jenniffer
    Rincon, Nataly
    Alexandra Aguilar, Yudy
    Vanessa Rueda, Zulma
    Herrera, Mariana
    Agustin Velez, Lazaro
    [J]. BIOMEDICA, 2011, 31 (02): : 222 - 231
  • [48] Detection of Pneumocystis jirovecii DHPS genotypes in bronchoalveolar lavages from immunocompromised patients at a University Hospital in Belgium
    Hernandez, I. Montesinos
    Brancart, F.
    Hites, M.
    Delforge, M.
    Jacobs, F.
    Denis, O.
    [J]. MYCOSES, 2015, 58 : 183 - 183
  • [49] Utility of adding Pneumocystis jirovecii DNA detection in nasopharyngeal aspirates in immunocompromised adult patients with febrile pneumonia
    Guigue, Nicolas
    Alanio, Alexandre
    Menotti, Jean
    De Castro, Nathalie
    Hamane, Samia
    Peyrony, Olivier
    LeGoff, Jerome
    Bretagne, Stephane
    [J]. MEDICAL MYCOLOGY, 2015, 53 (03) : 241 - 247
  • [50] Pneumocystis jirovecii (Pj) quantitative PCR to differentiate Pj pneumonia from Pj colonization in immunocompromised patients
    M. Maillet
    D. Maubon
    J. P. Brion
    P. François
    L. Molina
    J. P. Stahl
    O. Epaulard
    A. Bosseray
    P. Pavese
    [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2014, 33 : 331 - 336
12345